Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Christopher J. Schaber, CEO, Soligenix Inc
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Soligenix's (NASDAQ:SNGX) Breakthrough Therapies for Rare Diseases
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:00:00
How dermatology company is improving the lives of patients suffering from skin diseases- Matt Callahan Executive Director, Botanix Pharmaceuticals Ltd
00:10:00
Yes Bank Strengthens Balance Sheet with ₹15,000 Crore FPO, Eyes Future Growth | Prashant Kumar, CEO , Yes Bank Ltd.
00:10:00
Golden Predator: Revitalizing Brewery Creek Gold Mine for Sustainable Production
00:10:00
Aerojet Rocketdyne is celebrating significant advancements, including securing its largest RL10 engine contract from United Launch Alliance and L3Harris's acquisition of the company, enhancing its propulsion and defense capabilities. Concurrently, Jeep CE
00:10:00
Acushnet Holdings CEO David Maher on Stock Performance and Golf Industry Outlook | David Maher, CEO , Acushnet Holding.
00:10:00
Nephew Tommy and NMSDC Unveil Virtual Conference: A Powerhouse Event for Minority Business Development|Adrienne Trimble,President & CEO,NMSDC
00:10:00
Navigating the Intersection of Politics and Medicine: Insights from a Health Ministry Veteran | Mr. Chi-Hsien Chan, CEO, Adimmune Corp .
00:10:00
Mike Turi's Essential Financial Tips for College Students
00:10:00
AI Interfaces and the Future of MLOps with Tristan Zajonc | Tristan Zajonc, CEO , Continual Ltd.
00:10:00
Enhancing Investor Returns: Wisdom Tree's Innovative Smart Beta Approach | Jonathan Steinberg, CEO ,WisdomTree Investments.
00:00:00
Joost de Bruijn, CEO, Kuros Biosciences
00:10:00
Nations Royalty: Empowering Indigenous Communities Through Capital Markets